# Bayer Venture Investments

Bayer Venture Investments is a Venture Capital based in St. Louis, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** St. Louis, United States
- **Region:** Europe
- **Address:** St. Louis, Missouri, United States
- **Assets under management:** Undisclosed
- **Website:** bayer.com
- **LinkedIn:** https://www.linkedin.com/company/bayer-venture-investments

## Regulatory record

- **Reports private funds:** No

## About

Bayer Venture Investments acts as the strategic venture arm of Bayer AG, the German pharmaceutical and agricultural giant. The unit was established to identify and fund external innovations that align with Bayer’s core businesses: pharmaceuticals, consumer health, and crop science. The investment strategy spans seed to growth-stage companies, with a focus on digital health, agritech, and industrial biotech. Bayer Venture Investments participates in syndicated rounds alongside traditional VCs and occasionally leads or co-invests directly. Confirmed portfolio positions include Recursion Pharmaceuticals, a drug-discovery platform using machine learning, and Ginkgo Bioworks, a synthetic-biology firm that develops engineered organisms for agriculture and pharma (public record, 2022). The geographic focus is North America, with additional activity in Europe and Asia. Bayer maintains multiple offices across the United States and Germany, though total team size is not publicly disclosed. The venture unit operates within Bayer’s corporate structure, separate from its operational divisions. No recent public funding round or major portfolio exit has been reported in the last 24 months. Structurally, Bayer Venture Investments distinguishes itself as a strategic corporate venture capital fund, prioritizing long-term alignment with Bayer’s R&D pipeline over purely financial returns. Its investment decisions are integrated with Bayer’s business units, allowing portfolio companies access to manufacturing, regulatory, and distribution expertise.

## Sectors

- Digital Health
- Healthcare Services
- AgriTech & FoodTech
- ClimateTech
- Industrial Tech

## Offices

- Cambridge, Massachusetts, United States
- Kansas City, Missouri, United States
- Jefferson City, Missouri, United States
- Leverkusen, Germany

## Questions

### How does Bayer Venture Investments source proprietary deal flow?

Deal flow comes through Bayer’s internal R&D divisions, academic partnerships, and general market scouting. The unit leverages Bayer’s extensive network in pharmaceuticals, crop science, and digital health to identify startups aligned with its strategic objectives.

### Is Bayer Venture Investments structured as a pure venture fund or does it operate like a strategic investor?

It operates as a strategic corporate venture capital arm. Investments are made to support Bayer’s business units, not purely for financial returns. This structure allows portfolio companies to access Bayer’s resources, including manufacturing, regulatory, and distribution channels.

### How is Bayer Venture Investments related to Bayer AG?

It is a wholly owned corporate venture capital subsidiary of Bayer AG, headquartered in St. Louis. The unit operates under Bayer’s overall corporate strategy, with investment decisions integrated with the company’s R&D and business development teams.

## Related profiles

- [Secure Erie Accelerator](https://altss.com/profile/secure-erie-accelerator)
- [TRP Infrastructure Services](https://altss.com/profile/trp-infrastructure-services)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/bayer-venture-investments

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology